Edition:
United Kingdom

Wright Medical Group NV (WMGI.OQ)

WMGI.OQ on NASDAQ Stock Exchange Global Select Market

24.99USD
20 Jul 2018
Change (% chg)

$-0.06 (-0.24%)
Prev Close
$25.05
Open
$25.04
Day's High
$25.20
Day's Low
$24.84
Volume
165,124
Avg. Vol
300,170
52-wk High
$29.87
52-wk Low
$19.02

Latest Key Developments (Source: Significant Developments)

Wright Medical Group buys IMASCAP SAS for $88.8 mln
Thursday, 14 Dec 2017 

Dec 14 (Reuters) - Wright Medical Group Nv ::WRIGHT MEDICAL GROUP N.V. ANNOUNCES ACQUISITION OF IMASCAP SAS.WRIGHT MEDICAL GROUP NV - DEAL FOR EUR 75.1 MILLION, OR APPROXIMATELY $88.8 MILLION.WRIGHT MEDICAL GROUP NV - COMPANY REITERATES PREVIOUSLY PROVIDED 2017 ANNUAL FINANCIAL GUIDANCE.WRIGHT MEDICAL GROUP - DEAL CONSIDERATION CONSISTS OF ABOUT $46.9 MILLION IN CASH AND ABOUT $15.6 MILLION OF CO'S SHARES.WRIGHT MEDICAL GROUP - DEAL CONSIDERATION ALSO CONSISTS OF ABOUT $26.3 MILLION IN POTENTIAL EARNOUTS AND MILESTONE PAYMENTS.  Full Article

Wright Medical Q3 loss per share $0.33 from continuing operations
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Wright Medical Group Nv ::Wright medical group n.v. Reports 2017 third quarter financial results and updated 2017 annual guidance.Q3 loss per share $0.33 from continuing operations.Q3 sales $170.5 million.Sees fy 2017 sales $740 million to $745 million.Wright medical group nv - ‍increases full-year 2017 non-gaap adjusted ebitda guidance to $84 million to $88 million​.Wright medical group nv - sees ‍non-gaap loss per share from continuing operations for full-year 2017 to be $0.28 to $0.24​.  Full Article

Wright Medical Group says Q2 loss per share $0.41 from continuing operations
Wednesday, 3 Aug 2016 

Wright Medical Group Nv : Wright medical group n.v. Reports 2016 second quarter financial results and increases 2016 guidance . Q2 sales $171 million . Q2 loss per share $0.41 from continuing operations . Sees fy 2016 sales $675 million to $685 million . Fy2016 earnings per share view $-0.61, revenue view $713.1 million -- Thomson Reuters I/B/E/S . Sees full-year 2016 non-gaap adjusted ebitda from continuing operations $40 million to $45 million . Anticipates adjusted cash loss per share from continuing operations for full-year 2016 of $0.54 to $0.47 .Q2 earnings per share view $-0.22, revenue view $172.5 million -- Thomson Reuters I/B/E/S.  Full Article

Wright Medical Group says Q2 loss per share $0.41 from continuing operations
Tuesday, 2 Aug 2016 

Wright Medical Group Nv : Wright medical group n.v. Reports 2016 second quarter financial results and increases 2016 guidance . Q2 sales $171 million . Q2 loss per share $0.41 from continuing operations . Sees fy 2016 sales $675 million to $685 million . Fy2016 earnings per share view $-0.61, revenue view $713.1 million -- Thomson Reuters I/B/E/S . Sees full-year 2016 non-gaap adjusted ebitda from continuing operations $40 million to $45 million . Anticipates adjusted cash loss per share from continuing operations for full-year 2016 of $0.54 to $0.47 .Q2 earnings per share view $-0.22, revenue view $172.5 million -- Thomson Reuters I/B/E/S.  Full Article